Clinical Trial Update: CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing whether lowering cholesterol with atorvastatin in people with type 2 diabetes but no prior cardiovascular disease reduces cardi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lipitor (atorvastatin) (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Major Coronary Event, Cerebrovascular Accident | Phase 4 | Status: COMPLETED